Clinical Trial Update: A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin D [Phase 1]

View source ↗

Summary

Phase 1 study reporting bioequivalence of 70 mg alendronate alone and in combination with 2800 IU vitamin D for osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Vitamin D (Cholecalciferol)
• alendronate (alendronate)

Snippet

Sponsor: Organon and Co | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED | Results posted: 2010-02-12